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CED-4ÐThe Third Horseman Minireview
of Apoptosis
David L. Vaux domain. By binding to CED-4, CED-9 somehow prevents
it from activating pro-CED-3.The Walter and Eliza Hall
Institute of Medical Research Regulation of Caspases by Adaptor Proteins
and BCL-2 Family ProteinsPost Office Royal Melbourne Hospital 3050
Victoria While many mammalian homologs of CED-9 have been
found (i.e., the BCL-2 family), and more than 10 mamma-Australia
lian caspases are known, until now homologs of CED-4
have been elusive. However, other mammalian caspase-
activating adaptor proteins have been identified. ForThe remarkable conservation of physiological cell death
example, Mort-1/FADD interacts with certain caspasesmechanisms from nematodes to humans has allowed
via shared death effector domains (DEDs) and RAIDD/the genetic pathways of programmed cell death deter-
CRADD interacts with other caspases via shared CARDsmined in Caenorhabditis elegans to act as a framework
to transduce proapoptotic signals, such as those origi-for understanding the biology of apoptosis in mamma-
nating from TNF family receptors (Hofmann et al., 1997).lian cells. However, it has been unclear whether the C.
In most cells, these cell death signals are poorly blockedelegans cell death gene ced-4 would have a parallel in
by BCL-2, whereas BCL-2 is potent at inhibiting cellmammalian cell death. In this issue of Cell, Zou et al.
death triggered by other stimuli, such as withdrawal of(1997) report the biochemical identification of a human
growth factor, or up-regulation of p53 (Strasser et al.,cell death protein whose sequence resembles the nema-
1995). It may be that the ability of BCL-2 to inhibittode protein CED-4, providing a spectacular demonstra-
apoptosis depends upon which adaptor molecule is in-tion of the combined power of genetic analysis of a
volved in caspase activation.simple organism with biochemistry of mammalian cells.
Determining precisely how BCL-2-like proteins func-The Genetic Framework
tion has been surprisingly difficult. In various experimen-Although the first cell death gene to be characterized
tal systems, BCL-2 has been found to interact with cal-at the molecular level was a mammalian gene, bcl-2,
cineurin, p53 binding protein, lamin, NIP-1, -2, and -3,genetic analysis of C. elegans mutants had already
R-RAS, RAF-1, BAG-1, and galectin-3, as well as inter-shown that, in the worm, physiological cell death re-
acting with other BCL-2 family members. Recently it hasquired the activity of two ``killer'' genes, ced-3 and ced-4
been proposed that BCL-2 functions by forming pores(Ellis and Horvitz, 1986). The discovery that human bcl-2
to allow ions or small molecules to cross the outer mito-has functional and structural similarity to the anti±cell
chondrial membrane (Reed, 1997). As release of cyto-death gene ced-9 demonstrated that programmed cell
chrome c from the intermitochondrial space has beendeath in the nematode occurred by the same highly
associated with apoptosis in a number of systems, andconserved mechanism as apoptosis in mammalian cells
as this release is prevented by BCL-2, it has been hy-(Vaux et al., 1992; Hengartner and Horvitz, 1994). The
pothesized that the key function of BCL-2-like proteinskiller gene ced-3 was found to encode a cysteine prote-
is to somehow retain cytochrome c in the mitochondria
ase with aspartic acid specificity (caspase) and was
(Kluck et al., 1997; Yang et al., 1997).
the archetype of a family of caspases that are the key
effector proteins of apoptosis in mammalian cells (Yuan
et al., 1993). The caspases are zymogens: they exist as
inactive polypeptides that can be activated by removal
of the regulatory prodomain and assembly into the ac-
tive heteromeric protease. The key questions then be-
came: What activates the caspases and what regulates
their activation?
Genetic studies suggested that ced-4 was required
for ced-3 function, whereas ced-9 regulated apoptosis
by preventing activation of the caspase encoded by
ced-3 (Ellis and Horvitz, 1986; Hengartner and Horvitz,
Figure 1. A Speculative Model for Caspase Activation1994). Recent biochemical data support theseconcepts,
Activation of caspases such as caspase-3 occurs in the presenceas CED-3 and CED-4 can physically interact (Chinnaiyan
of dATP, cytochrome c (Apaf-2), Apaf-3, and Apaf-1. The caspaseet al., 1997; Irmler et al., 1997), most likely by virtue of
precursor is cleaved, allowing removal of the prodomain and assem-
their N-terminal domains, which both contain a motif bly of other subunits into the proteolytically active conformation.
designated a caspase recruitment domain (CARD) (Hof- Apaf-1 (or other adaptor molecules such as CED-4 in C. elegans)
may interact with the caspase precursors via domains such as cas-mann et al., 1997). Furthermore, CED-9 and CED-4 have
pase recruitment domains (CARDs) or death effector domainsbeen found to directly interact when expressed in yeast
(DEDs). The nature of Apaf-3 (depicted by black box) remains to beand in mammalian cells (Chinnaiyan et al., 1997; James
determined, as does the configuration of the physical interactionet al., 1997; Spector et al., 1997; Wu et al., 1997). There-
bewteen cytochrome c, Apaf-1, and Apaf-3. BCL-2-like proteins
fore, in C. elegans it appears that CED-4 is an adaptor inhibit caspase activation by either binding directly to the adaptor
protein that can receive an apoptotic signal, bind to pro- protein (Apaf-1 or CED-4), preventing release of cytochrome c, or
both.CED-3, and cause it to release its activated proteolytic
Cell
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The genetics of cell death in C. elegans and biochemi- in physiological circumstances, or does another nucleo-
tide play this role? What is the role of nucleotide bind-cal evidence of a direct interaction between CED-9 and
ingÐdoes it act as a switch to change the conformationCED-4 suggest that, before we can really understand
and activity of Apaf-1, as occurs in G proteins, or is ATPhow BCL-2-like proteins function, we will need to find
used as energy to drive a reaction? What protein isthe mammalian homolog(s) of CED-4. This search now
responsible for cleaving the caspase precursorÐis itappears to be over.
autocatalytic, or can one of the Apafs act as a protease?A Human Protein Resembling CED-4
What is the identity of Apaf-3Ðwill it turn out to resembleUsing a biochemical approach to analyze cytosolic pro-
known proteins, such as one of the proapoptotic BCL-2teins that can activate caspase-3, Xiaodong Wang and
family members, or will it be completely novel? What iscoworkers have isolated a number of Apoptosis activat-
the relationship, if any, between Apafs 1±3 and apo-ing factors (Apafs 1±3) (Zou et al., 1997). Addition of
ptosis-inducing factor (AIF), a 50 kDa caspase activat-dATP to these purified proteins results in cleavage and
ing protein released from the mitochondria (Kroemer,activation of the caspase-3 precursor. Earlier work re-
1997)? Do human BCL-2-like proteins bind to humanvealed Apaf-2 to be cytochrome c, which was released
CED-4-like proteins? Apoptosis remains one of the hot-from the mitochondria during homogenization. Apaf-3
test areas of biological research. Chances are we won'tis a 45 kDa protein that has not yet been cloned. Apaf-1
have to wait long to find out.was found to resemble CED-4. It has an amino-terminal
CARD domain and a 320 amino acid central portion with
Selected Reading22% identity and 48% similarity to CED-4. The carboxy-
terminal half of Apaf-1 has 12 WD40 motifs that are Chinnaiyan, A.M., O'Rourke, K., Lane, B.R., and Dixit, V.M. (1997).
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CED-4 prevented it from promoting caspase activation James, C., Gschmeissner, S., Fraser, A., and Evan, G.I. (1997). Curr.
Biol. 7, 246±252.in insect cells, as well as death of S.pombe overexpress-
ing ced-4 (James et al., 1997; Seshagiri and Miller, 1997). Kluck, R.M., Bossywetzel, E., Green, D.R., and Newmeyer, D.D.
(1997). Science 275, 1132±1136.Using purified components, Zou et al. have shown
Kroemer, G. (1997). Immunol. Today 18, 44±51.that cytochrome c, dATP, the CED-4 homolog Apaf-1,
Reed, J.C. (1997). Nature 387, 773±776.and Apaf-3 are sufficient to activate pro-caspase-3,
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Spector, M.S., Desnoyers, S., Hoeppner, D.J., and Hengartner, M.O.the CED-4 component of the apoptotic mechanism is
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1957.We still do not know precisely how BCL-2/CED-9-like
Wu, D.Y., Wallen, H.D., and Nunez, G. (1997). Science 275, 1126±proteins work. If they prevent apoptosis by blocking
1129.
cytochrome c release, why would they need to bind to
Yang, J., Liu, X.S., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J.Y., Peng,
CED-4 proteins, and what is the role of BCL-2 in other T.I., Jones, D.P., and Wang, X.D. (1997). Science 275, 1129±1132.
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proteins function by binding to and inhibiting CED-4, Zou, H., Henzel, W.J., Liu, X., Lutschg, A., and Wang, X. (1997). Cell
why would they need to prevent cytochrome c release? this issue, 90, 405±413.
It may be that BCL-2 proteins perform both functions.
Another possibility is that BCL-2 may retain cytochrome
c in the mitochondria indirectly. If cytochrome c was
only one of a number of factors that can cause CED-4 to
activate the caspases, induction of apoptosis by these
alternate pathways might lead to a secondary loss of
mitochondrial function, release of cytochrome c, and
an amplification of the apoptotic cascade. In such a
scenario, BCL-2-like proteins would only act as CED-4
inhibitors, with their ability to prevent cytochrome c re-
lease being indirect, by inhibiting the initial, premito-
chondrial caspase activation.
Clearly, the experiments of Wang and coworkers have
answered some questions but, like much good research,
generated still more: Is dATP a regulator of apoptosis
